The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Peptides Lack Reliable Safety Information, Watchdog Warns The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks Canada.ca